UC San Francisco Cell Therapy Raises Hope for Severe Human Forms
Epilepsy that does not respond to drugs can be halted in adult mice by transplanting a specific type of cell into the brain, UC San Francisco researchers have discovered, raising hope that a similar treatment might work in severe forms of human epilepsy.
UCSF scientists controlled seizures in epileptic mice with a one-time transplantation of medial ganglionic eminence (MGE) cells, which inhibit signaling in overactive nerve circuits, into the hippocampus, a brain region associated with seizures, as well as with learning and memory. Other researchers had previously used different cell types in rodent cell transplantation experiments and failed to stop seizures.
Cell therapy has become an active focus of epilepsy research, in part because current medications, even when effective, only control symptoms and not underlying causes of the disease, according to Scott C. Baraban, PhD, who holds the William K. Bowes Jr. Endowed Chair in Neuroscience Research at UCSF and led the new study. In many types of epilepsy, he said, current drugs have no therapeutic value at all.
“Our results are an encouraging step toward using inhibitory neurons for cell transplantation in adults with severe forms of epilepsy,” Baraban said. “This procedure offers the possibility of controlling seizures and rescuing cognitive deficits in these patients.”
The findings, which are the first ever to report stopping seizures in mouse models of adult human epilepsy, will be published online May 5 in the journal Nature Neuroscience.
During epileptic seizures, extreme muscle contractions and, often, a loss of consciousness can cause seizure sufferers to lose control, fall and sometimes be seriously injured. The unseen malfunction behind these effects is the abnormal firing of many excitatory nerve cells in the brain at the same time.
In the UCSF study, the transplanted inhibitory cells quenched this synchronous, nerve-signaling firestorm, eliminating seizures in half of the treated mice and dramatically reducing the number of spontaneous seizures in the rest. Robert Hunt, PhD, a postdoctoral fellow in the Baraban lab, guided many of the key experiments.
In another encouraging step, UCSF researchers reported May 2 that they found a way to reliably generate human MGE-like cells in the laboratory, and that, when transplanted into healthy mice,the cells similarly spun off functional inhibitory nerve cells. That research can be found online in the journal Cell Stem Cell.
In many forms of epilepsy, loss or malfunction of inhibitory nerve cells within the hippocampus plays a critical role. MGE cells are progenitor cells that form early within the embryo and are capable of generating mature inhibitory nerve cells called interneurons. In the Baraban-led UCSF study, the transplanted MGE cells from mouse embryos migrated and generated interneurons, in effect replacing the cells that fail in epilepsy. The new cells integrated into existing neural circuits in the mice, the researchers found.
“These cells migrate widely and integrate into the adult brain as new inhibitory neurons,” Baraban said. “This is the first report in a mouse model of adult epilepsy in which mice that already were having seizures stopped having seizures after treatment.”
The mouse model of disease that Baraban’s lab team worked with is meant to resemble a severe and typically drug-resistant form of human epilepsy called mesial temporal lobe epilepsy, in which seizures are thought to arise in the hippocampus. In contrast to transplants into the hippocampus, transplants into the amygdala, a brain region involved in memory and emotion, failed to halt seizure activity in this same mouse model, the researcher found.
The Latest Bing News on:
Epilepsy
- ‘You could have gotten somebody killed’: Teen girl with epilepsy held at gunpoint during Pinellas traffic stopon May 7, 2024 at 3:41 pm
A Tampa attorney said a traffic stop that happened in Pinellas County on Jan. 1 should have never happened. Pinellas County deputies soon realized they’d made a mistake, and one of the deputies ...
- Epilepsy Foundation set to host Epilepsy Walk this weekendon May 6, 2024 at 11:17 pm
COLLEGE STATION, Texas (KBTX) - In an effort to raise awareness, the Epilepsy Foundation of Bryan College Station will host a walk on Saturday, May 11 at 9:30 a.m. at Wolf Pen Creek Park. You can ...
- Missing at-risk man with epilepsy being sought in San Franciscoon May 6, 2024 at 3:16 pm
The search is on in San Francisco for an at-risk man with epilepsy who went missing nearly a week ago while visiting the city for a band audition, according to family.
- ERs Often Missing Epilepsy in Kids With 'Non-Motor' Seizureson May 6, 2024 at 3:11 am
French's team focused on non-motor seizures, a more subtle form of the disease in which kids “zone out” and stare into space or fidget. During these seizures, they may also experience sudden changes ...
- Study shows impact of education on epilepsy care in Saudi Arabiaon May 5, 2024 at 5:00 pm
Epilepsy is a neurological condition characterized by recurrent seizures, which can lead to various psychological problems. While most cases are idiopathic, some may result from brain injury, stroke, ...
- Mental Health Therapy Proves Beneficial for Children With Epilepsyon May 5, 2024 at 5:00 pm
Compared with children with epilepsy who received assessment-enhanced usual care, those who received MICE therapy demonstrated improved symptoms of emotional and behavioral difficulties. Young ...
- Epilepsy Newson May 4, 2024 at 5:00 pm
Nov. 30, 2023 — Slow waves that usually only occur in the brain during sleep are also present during wakefulness in people with epilepsy and may protect against increased brain excitability ...
- Penn Medicine neurosurgeon first in U.S. to implant new medical device for patients with Parkinson’s, epilepsyon May 3, 2024 at 7:12 am
Medtronic’s Percept™ RC neurostimulator is the first and only rechargeable deep brain stimulation system with sensing, directionality, and advanced programming.
- Sleep Apnea Linked With Late-Life Epilepsyon May 2, 2024 at 2:46 am
There's now a strong link between sleep apnea and the emergence of epilepsy in late life. It's possible that the interrupted breathing and lowered oxygen levels of ...
- Emergency departments may frequently miss signs of epilepsy in childrenon May 1, 2024 at 1:00 pm
A subtle type of seizure goes undetected two thirds of the time in pediatric emergency departments, a new study shows.
The Latest Google Headlines on:
Epilepsy
[google_news title=”” keyword=”Epilepsy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Cell therapy
- Black 12-Year-Old Patient Begins New Sickle Cell Therapy Treatmenton May 7, 2024 at 8:39 am
A 12-year-old Black patient is the first to undergo a new gene therapy treatment for sickle cell disease, according to reports.
- €2.6 Million Funding Boosts Ground-breaking CAR T Cell Therapy Study in Advanced Lymphomason May 7, 2024 at 8:30 am
Million Funding Boosts Ground-breaking CAR T Cell Therapy Study in Advanced Lymphomas Dr. Kerstin Wild Stabsstelle „Strategische Entwicklung“ Leibniz ...
- AI predicts tumor-killing cells with high accuracy, study showson May 7, 2024 at 8:23 am
Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer-killing immune cells for use in cancer ...
- Vertex files FDA approval ask for next-gen cystic fibrosis candidate, resumes diabetes cell therapy trialon May 7, 2024 at 4:30 am
Now, Vertex is asking for the FDA to approve vanza triple for people with CF aged 6 years and older. The Boston-based company also completed a submission in Europe for the same indication and is on ...
- World's first patient begins sickle cell gene therapy treatment: What is it?on May 7, 2024 at 4:12 am
Doctors in the US spent hours removing stem cells from the bone marrow of 12-year-old Kendric Cromer. These cells will be sent to a lab in New Jersey where researchers will infuse a healthy ...
- Caring Cross and ImmunoAdoptive Cell Therapy (ImmunoACT) Announce Agreement to Commercialize TriCAR-T Cell Immunotherapy for Leukemia and Lymphomaon May 7, 2024 at 1:00 am
Agreement allows ImmunoACT to develop and commercialize a novel TriCAR-T cell therapy for leukemia and lymphoma designed to decrease lapses seen in current single CAR-T cell therapies and improve ...
- Cellipont Bioservices and Adva Biotechnology Collaborate to Optimize Cell Therapy Manufacturing with the ADVA X3® Platformon May 7, 2024 at 12:24 am
THE WOODLANDS, Texas, and HAIFA, Israel, May 7, 2024 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Adva Biotechnology, ...
- AstraZeneca ups stake in Cellectis in latest cell therapy beton May 6, 2024 at 9:57 am
The British drugmaker, which has made genetic medicine a larger priority of late, added $140 million to a deal to develop up to 10 gene and cell therapies.
- ASGCT 2024 Comes at Pivotal Time for Gene and Cell Therapy Sectoron May 5, 2024 at 9:06 pm
Jeffrey Chamberlain, president of the American Society of Gene & Cell Therapy, spoke with BioSpace about what we can expect to learn about in Baltimore this week.
- Preclinical study finds novel stem cell therapy boosts neural repair after cardiac arreston May 1, 2024 at 10:13 am
Researchers at the University of Maryland School of Medicine (UMSOM) have identified an innovation in stem cell therapy to regenerate neural cells in the brain after cardiac arrest in an animal model.
The Latest Google Headlines on:
Cell therapy
[google_news title=”” keyword=”Cell therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]